PHILADELPHIA, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences company focused on advancing the clinical ...
Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 ...
Medicus Pharma is not obligated to sell any shares under the agreement and has not provided assurance regarding the price, amount, or timing of any potential sales. The offering will terminate upon ...
Prologue In the early 1970s, I wrote my Ph.D. thesis on Adamantios Koraes at the University of Wisconsin. I read his ...
What is the current share price of Pro Medicus Limited (PME)? Pro Medicus Limited's (PME) current share price is $222.63. This constitutes a price movement of 1.35% when compared to the share price 7 ...
Pro Medicus Ltd has a price-to-earnings (P/E) ratio of 185.18 (TTM). This compares to an industry average of 32.78. What is Pro Medicus Ltd’s price-to-sales ratio? The P/S ratio for Pro Medicus Ltd is ...
) has been revised to $20.06 / share. This is a decrease of 11.94% from the prior estimate of $22.78 dated December 18, 2025. The price target is an average of many targets provided by analysts. The ...
Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...
RICHARDSON, TX / ACCESS Newswire / January 5, 2026 / Optex Systems Holdings, Inc. (Nasdaq:OPXS), a leading manufacturer of precision optical sighting systems for domestic and worldwide military and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results